Gilead Sciences, Inc. (GILD)
NASDAQ·Healthcare·Drug Manufacturers - General
$150.86
-0.01%
Mkt Cap $187.34B
Analyst Ratings
Buy
13
Hold
1
Sell
0
Price Target (105 analysts)
$150.00
Range $123.00 – $175.00
Implied Upside
-0.6%
Consensus $150.00 vs current $150.86